(Q31122163)

29 June 2017

title

Study of the risk factors for severe childhood pertussis based on hospital surveillance data (English)

1 reference

29 June 2017

Valérie Briand

1

1 reference

29 June 2017

Isabelle Bonmarin

series ordinal

2

1 reference

29 June 2017

Daniel Lévy-Bruhl

series ordinal

3

1 reference

29 June 2017

language of work or name

English

0 references

publication date

2 August 2007

1 reference

29 June 2017

1 reference

29 June 2017

volume

25

1 reference

29 June 2017

issue

41

1 reference

29 June 2017

page(s)

7224-7232

1 reference

Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.020

Resurgence of pertussis in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.020

Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a french area with very high whole-cell vaccine coverage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.020

Outcomes of Bordetella pertussis infection in different age groups of an immunized population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.020

Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.020

Vaccine coverage of pre-school age children in France in 2000

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.020

Bordetella pertussis surveillance in England and Wales: 1995-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.020

Intensity of exposure and severity of whooping cough

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.020

Increased risk of reported pertussis and hospitalization associated with pertussis in low birth weight children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.020

Hospitalization and complications in children under 2 years of age with Bordetella pertussis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.020

Epidemiological features of pertussis in the United States, 1980-1989.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.020

Epidemiological Features of Pertussis in Hospitalized Patients in Canada, 1991‐1997: Report of the Immunization Monitoring Program–Active (IMPACT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.020

Clinical and microbiologic features of children presenting with pertussis to a Canadian pediatric hospital during an eleven-year period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.020

Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.020

Delayed immunisation and risk of pertussis in infants: unmatched case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.020

Effects of Pertussis Vaccination on Disease: Vaccine Efficacy in Reducing Clinical Severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.020

10.1016/J.VACCINE.2007.07.020

7 January 2021

Identifiers

DOI

1 reference

29 June 2017

1 reference